187 related articles for article (PubMed ID: 20051841)
21. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
22. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
23. Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants.
Vu D; Di Sanza C; Neerman-Arbez M
Haematologica; 2008 Feb; 93(2):224-31. PubMed ID: 18223281
[TBL] [Abstract][Full Text] [Related]
24. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200+1G>T]).
Angles-Cano E; Mathonnet F; Dreyfus M; Claeyssens S; de Mazancourt P
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):73-5. PubMed ID: 17179831
[TBL] [Abstract][Full Text] [Related]
25. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family.
Neerman-Arbez M; Vu D; Abu-Libdeh B; Bouchardy I; Morris MA
Blood; 2003 May; 101(9):3492-4. PubMed ID: 12511408
[TBL] [Abstract][Full Text] [Related]
26. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
27. Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
Asselta R; Duga S; Simonic T; Malcovati M; Santagostino E; Giangrande PL; Mannucci PM; Tenchini ML
Blood; 2000 Oct; 96(7):2496-500. PubMed ID: 11001902
[TBL] [Abstract][Full Text] [Related]
28. The molecular basis of inherited afibrinogenaemia.
Neerman-Arbez M
Thromb Haemost; 2001 Jul; 86(1):154-63. PubMed ID: 11487003
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of congenital afibrinogenaemia in a Dutch family.
Remijn JA; van Wijk R; Nieuwenhuis HK; de Groot PG; van Solinge WW
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):299-302. PubMed ID: 12695755
[TBL] [Abstract][Full Text] [Related]
30. A nonsense mutation in FGA g.3807C-->T (p.R159X) causes afibrinogenaemia in the homozygous form.
Marchi Cappelletti R; Tersek Y; Ruiz-Sáez A; Meyer M
Acta Haematol; 2009; 121(4):216-7. PubMed ID: 19468208
[No Abstract] [Full Text] [Related]
31. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
32. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
[TBL] [Abstract][Full Text] [Related]
33. Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
Spena S; Duga S; Asselta R; Malcovati M; Peyvandi F; Tenchini ML
Blood; 2002 Dec; 100(13):4478-84. PubMed ID: 12393540
[TBL] [Abstract][Full Text] [Related]
34. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
[TBL] [Abstract][Full Text] [Related]
35. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia.
Spena S; Asselta R; Platé M; Castaman G; Duga S; Tenchini ML
Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel mutation in congenital afibrinogenemia in Iranian patients.
Nojehdeh ST; Mojbafan M; Masoodifard M; Amini M; Zeinali S
Blood Coagul Fibrinolysis; 2021 Jul; 32(5):323-327. PubMed ID: 33901106
[TBL] [Abstract][Full Text] [Related]
37. Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia.
Neerman-Arbez M; Honsberger A; Antonarakis SE; Morris MA
J Clin Invest; 1999 Jan; 103(2):215-8. PubMed ID: 9916133
[TBL] [Abstract][Full Text] [Related]
38. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.
Casini A; Lukowski S; Quintard VL; Crutu A; Zak M; Regazzoni S; de Moerloose P; Neerman-Arbez M
Thromb Res; 2014 May; 133(5):868-74. PubMed ID: 24560896
[TBL] [Abstract][Full Text] [Related]
39. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
40. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
